Response to the letter to the editor: 'Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia'

Expert Opin Pharmacother. 2024 Dec 8:1-2. doi: 10.1080/14656566.2024.2437524. Online ahead of print.
No abstract available

Keywords: APOC3 antisense; Olezarsen; thrombocytopenia; volanesorsen.